In this tutorial, the application of experimental designs in separation science is discussed. Method optimization is often divided into screening and optimization phases. In the screening step, many factors, potentially affecting the separation, are screened to identify those with the largest effects. These are then further examined in an optimization phase, to determine the best separation conditions. After optimizing the method, it should be validated, before use for quantitative purposes. Robustness testing is part of method validation and examines the effects on the responses of small changes in method conditions. During the first phase of method optimization and during robustness testing, so-called screening designs are usually applied, whereas during the second phase of optimization, response-surface designs are often used. In this tutorial, the different steps in the application of both types of design are explained and elaborated with some examples.
[1]. Y. Vander Heyden C. Perrin D.L. Massart 2000 Optimization Strategies for HPLC and CZE K. Valkó Handbook of Analytical Separations, Vol. 1, Separation Methods in Drug Synthesis and Purification Elsevier Amsterdam 163–212.
[2]. B. Dejaegher , A. Durand, and Y. Vander Heyden, Experimental design in method optimization and robustness testing, In G. Hanrahan and F.A. Gomez (Eds.), Chemometric Methods in Capillary Electrophoresis, John Wiley & Sons, New Jersey, in press.
[3]. US Food and Drug Administration (FDA), Department of Health and Human Services, Validation of Chromatographic methods, CMC3, 1994, http://www.fda.gov/ (accessed on November 19th 2008).
[4]. Guidelines prepared within the International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH), Validation of Analytical Procedures: Text and Methodology, Q2(R1), 2005, pp. 1–13, http://www.ich.org/ (accessed on November 19th 2008).
[5]. Y. Vander Heyden D.L. Massart 1996 Review of Robustness in Analytical Chemistry M.W.B. Hendriks J.H. de Boer A.K. Smilde Robustness of Analytical Chemical Methods and Pharmaceutical Technological Products Elsevier Amsterdam 79–147.
[6]. Y. Vander Heyden A. Nijhuis J. Smeyers-Verbeke B.G.M. Vandeginste D.L. Massart 2001 J. Pharm. Biomed. Anal. 24 723.
[7]. United States Pharmacopoeia 29th edn, National Formulary 24th edn, United States Pharmacopeial Convention, Rockville, MD, USA, 2006.
[8]. W.J. Youden E.H. Steiner 1975 Statistical Manual of the Association of Official Analytical Chemists Association of Official Analytical Chemists Washington, DC.
[9]. D.L. Massart B.G.M. Vandeginste L.M.C. Buydens S. De Jong P.J. Lewi J. Smeyers-Verbeke 1997 Handbook of Chemometrics and Qualimetrics: Part A Elsevier Amsterdam.
[10]. B. Dejaegher Y. Vander Heyden 2009 Sequential Optimization Methods S. Brown R. Tauler B. Walczak Comprehensive Chemometrics, Volume 1, Chapter 17 Elsevier Oxford 547–575.
[11]. F.H. Walters L.R. Parker S.L. Morgan S.N. Deming 1991 Sequential Simplex Optimization, A Technique for Improving Quality and Productivity in Research, Development, and Manufacturing CRC Press Florida.
[12]. J. Gabrielsson N.-O. Lindberg T. Lundstedt 2002 J. Chemometrics 16 141.
[13]. B. Dejaegher Y. Vander Heyden 2008 Robustness Tests of CE Methods M. Jimidar S. Ahuja Capillary Electrophoresis Methods for Pharmaceutical Analysis Elsevier Amsterdam 185–224.
[14]. C. Perrin H. Fabre D.L. Massart Y. Vander Heyden 2003 Electrophoresis 24 2469.
[15]. Y. Vander Heyden F. Questier D.L. Massart 1998 J. Pharm. Biomed. Anal. 18 43.
[16]. J.A. van Leeuwen L.M.C. Buydens B.G.M. Vandeginste G. Kateman P.J. Schoenmakers M. Mulholland 1991 Chemometrics Intell. Lab. Syst. 10 337.
[17]. R. Gotti S. Furlanetto V. Andrisano V. Cavrini S. Pinzauti 2000 J. Chromatogr. A 875 411.
[18]. Eurachem, A Focus for Analytical Chemistry in Europe, Quantifying Uncertainty in Analytical Measurement, 1st edn, Berlin, 1995.
[19]. D.C. Montgomery 1997 Design and analysis of experiments 4th edition J. Wiley New York.
[20]. J.A. van Leeuwen L.M.C. Buydens B.G.M. Vandeginste G. Kateman P.J. Schoenmakers M. Mulholland 1991 Chemometrics Intell. Lab. Syst. 11 37.
[21]. J.A. van Leeuwen L.M.C. Buydens B.G.M. Vandeginste G. Kateman A. Cleland M. Mulholland C. Jansen F.A. Maris P.H. Hoogkamer J.H.M. van den Berg 1991 Chemometrics Intell. Lab. Syst. 11 161.
[22]. F. Questier Y. Vander Heyden D.L. Massart 1998 J. Pharm. Biomed. Anal. 18 287.
[23]. D. Mathieu , J. Nony, and R. Phan-Tan-Luu, NEMROD (New Efficient Methodology for Research using Optimal Designs) Software, LPRAI, Marseille, France, http://www.nemrodw.com/ (accessed on November 28th 2008).
[24]. Modde, Umetrics, Umea, Sweden, http://www.umetrics.com/ (accessed on November 28th 2008).
[25]. Statgraphics, Manugistics Inc., Rockville, USA, http://www.statgraphics.com/ (accessed on November 28th 2008).
[26]. Design Ease and Design Expert, Stat-Ease Inc., Minneapolis, USA, http://www.statease.com/ (accessed on November 28th 2008).
[27]. Minitab, Minitab Inc., Pennsylvania, USA, http://www.minitab.com/ (accessed on November 28th 2008).
[28]. Unscrambler, Camo Software Inc., Woodbridge, USA, http://www.camo.com/ (accessed on November 28th 2008).
[29]. SAS, SAS Institute, North Carolina, USA, Inc., http://www.sas.com/ (accessed on November 28th 2008).
[30]. R.L. Plackett J.P. Burman 1946 Biometrika 33 302.
[31]. C. Perrin G. Coussot I. Lefebvre C. Périgaud H. Fabre 2006 J. Chromatogr. A 1111 139.
[32]. Y. Vander Heyden A. Bourgeois D.L. Massart 1997 Anal. Chim. Acta 347 369.
[33]. Y. Vander Heyden M.S. Khots D.L. Massart 1993 Anal. Chim. Acta 276 189.
[34]. J. Goupy 1993 Methods for Experimental Design, Principles and Applications for Physicists and Chemists Elsevier Amsterdam.
[35]. SPSS, SPSS Inc., New York, USA, http://www.spss.com/ (accessed on January 20th 2009).
[36]. N.R. Draper H. Smith 1981 Applied Regression Analysis 2nd edn Wiley New York 101–102.
[37]. E. Morgan 1991 Chemometrics: Experimental Design, Analytical Chemistry by Open Learning Wiley Chichester.
[38]. Y. Vander Heyden K. Luypaert C. Hartmann D.L. Massart J. Hoogmartens J. De Beer 1995 Anal. Chim. Acta 312 245.
[39]. F. Dong 1993 Stat. Sin. 3 209.
[40]. B. Dejaegher X. Capron J. Smeyers-Verbeke Y. Vander Heyden 2006 Anal. Chim. Acta 564 184.
[41]. B. Dejaegher , A. Durand, and Y. Vander Heyden, J. Chromatogr. B, in press, doi:10.1016/j.jchromb.2008.10.019.
[42]. Y. Vander Heyden M. Jimidar E. Hund N. Niemeijer R. Peeters J. S.- Verbeke D.L. Massart J. Hoogmartens 1999 J. Chromatogr. A 845 145.
[43]. L. Živanović , A. Protić, M. Zečević, B. Jocić, and M. Kostić, J. Pharm. Biomed. Anal., in press, doi:10.1016/j.jpba.2008.09.052.
[44]. R. Ficarra P. Cutroneo Z. Aturki S. Tommasini M.L. Calabrò R. Phan-Tan-Luu S. Fanali P. Ficarra 2002 J. Pharm. Biomed. Anal. 29 989.
[45]. G.E.P. Box D.W. Behnken 1960 Ann. Math. Stat. 31 838.
[46]. D.H. Doehlert 1970 Appl. Statist. 19 231.
[47]. B. Bourguignon P.F. de Aguiar M.S. Khots D.L. Massart 1994 Anal. Chem. 66 893.
[48]. M. Jimidar P.F. de Aguiar S. Pintelon D.L. Massart 1997 J. Pharm. Biomed. Anal. 15 709.
[49]. P.F. de Aguiar B. Bourguignon M.S. Khots D.L. Massart R. Phan-Than-Luu 1995 Chemometrics Intell. Lab. Syst. 30 199.
[50]. R.W. Kennard L.A. Stone 1969 Technometrics 11 137.
[51]. A.K. Smilde A. Knevelman P.M.J. Coenegracht 1986 J. Chromatogr. 369 1.
[52]. H.R. Keller D.L. Massart J.P. Brans 1991 Chemometrics Intell. Lab. Syst. 11 175.
[53]. G. Derringer R. Suich 1980 J. Qual. Technol. 12 214.
[54]. B. Bourguignon D.L. Massart 1991 J. Chromatogr. A 586 11.